Imran Chaudry, MD
Cardiovascular Disease · Monroe, LANPI 1194763870
Payments from drug & device makers
Across 330 payments — averaging $1124.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Imperative Care, Inc$182K
- Tulavi Therapeutics, Inc.$66K
- Siemens Medical Solutions USA, Inc.$64K
- Qapel Medical Inc$31K
- Microvention, Inc.$20K
- Medtronic$4K
- plus $5K from 26 others
Across 10 payments — averaging $7161.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Imperative Care, Inc$72K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Imperative Care, Inc | 36 | $181,564 |
| Tulavi Therapeutics, Inc. | 1 | $65,897 |
| Siemens Medical Solutions USA, Inc. | 42 | $63,628 |
| Qapel Medical Inc | 4 | $31,364 |
| Microvention, Inc. | 22 | $19,701 |
| Medtronic(2 entities) | 77 | $4,393 |
| Penumbra, Inc. | 3 | $1,548 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 66 | $1,015 |
| Novartis | 19 | $361 |
| Merck | 9 | $208 |
| Abbott | 8 | $182 |
| Cardiovascular Systems Inc. | 9 | $165 |
| Stryker | 4 | $162 |
| Johnson & Johnson(2 entities) | 3 | $145 |
| Rapid Medical Ltd | 1 | $138 |
| W. L. Gore & Associates, Inc. | 1 | $119 |
| Lexicon Pharmaceuticals, Inc. | 5 | $83 |
| Amgen | 4 | $73 |
| Novo Nordisk | 2 | $53 |
| Pfizer | 2 | $45 |
| Acera Surgical, Inc. | 1 | $43 |
| Balt USA, LLC | 1 | $27 |
| Innovation Technologies Inc | 1 | $24 |
| Abiomed | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
| Itamar Medical Inc | 1 | $16 |
| Checkpoint Surgical, Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
How this compares
$371,080 in reported general payments places this provider in the 95th percentile of 281 cardiovascular disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Monroe
- Mazen IqbalMonroe$82K
- Ghiath MikdadiHammond$5.7M
- Marc BernsteinSlidell$2.1M
- Anil ChhabraShreveport$1.9M
- Dale PresserCovington$1.7M
- William EavesShreveport$1.6M
- Assad MouhaffelWest Monroe$1.4M
- Wenwu ZhangShreveport$1.1M
- William SmithRuston$694K
- Keith FerdinandNew Orleans$335K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.